Search Results for: C1orf50

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
Novel CLSPN claspin
  • Apoptotic cleavage of cellular proteins
  • Activation of ATR in response to replication stress
  • Ub-specific processing proteases
  • Processing of DNA double-strand break ends
Novel EXO5 exonuclease 5
Novel PPCS phosphopantothenoylcysteine synthetase
  • Coenzyme A biosynthesis
Novel ZMYND12 zinc finger MYND-type containing 12
ADCY4 adenylate cyclase 4
  • Glucagon signaling in metabolic regulation
  • PKA activation
  • PKA activation in glucagon signalling
  • Adenylate cyclase activating pathway
  • Adenylate cyclase inhibitory pathway
  • Adenylate cyclase inhibitory pathway
  • G alpha (s) signalling events
  • G alpha (s) signalling events
  • G alpha (i) signalling events
  • G alpha (z) signalling events
  • G alpha (z) signalling events
  • Vasopressin regulates renal water homeostasis via Aquaporins
  • Hedgehog 'off' state
  • ADORA2B mediated anti-inflammatory cytokines production
  • ADORA2B mediated anti-inflammatory cytokines production
  • FCGR3A-mediated IL10 synthesis
AHCY adenosylhomocysteinase
  • Methylation
  • Sulfur amino acid metabolism
  • Metabolism of ingested SeMet, Sec, MeSec into H2Se
  • Defective AHCY causes Hypermethioninemia with S-adenosylhomocysteine hydrolase deficiency (HMAHCHD)
  • (1'R,2'S)-9-(2-Hydroxy-3'-Keto-Cyclopenten-1-yl)Adenine
  • 3'-Oxo-Adenosine
  • D-Eritadenine
  • Copper
  • Hypermethioninemia; Methionine adenosyltransferase deficiency; S-adenosylhomocysteine hydrolase deficiency
APPBP2 amyloid beta precursor protein binding protein 2
CRX cone-rod homeobox
  • Leber congenital amaurosis (LCR)
  • Cone-rod dystrophy and cone dystrophy, including: Cone-rod dystrophy (CORD); Cone dystrophy (COD); Retinal cone dystrophy (RCD)
EIF2B1 eukaryotic translation initiation factor 2B subunit alpha
  • Recycling of eIF2:GDP
  • Leukoencephalopathy with vanishing white matter; Vanishing white matter disease; Childhood ataxia with diffuse central nervous system hypomyelination (CACH); Cree leukoencephalopathy (CLE)
EPM2AIP1 EPM2A interacting protein 1
INCA1 inhibitor of CDK, cyclin A1 interacting protein 1
LRP2BP LRP2 binding protein
MEOX1 mesenchyme homeobox 1
MEOX2 mesenchyme homeobox 2
NTAQ1 N-terminal glutamine amidase 1
REL REL proto-oncogene, NF-kB subunit
  • Activation of NF-kappaB in B cells
  • Hodgkin lymphoma
TCF4 transcription factor 4
  • Myogenesis
  • Myogenesis
  • Pitt-Hopkins syndrome, including: Pitt-Hopkins syndrome; Pitt-Hopkins-like syndrome

Page 1 out of 1 pages